Dare Bioscience, Inc. (DARE) stock
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.16 (-26.57%)
Close on Nov 17, 2026Market cap $6.56MP/E –Yield –
Dare Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Dare Bioscience's total debt was $10.54K at Sep 30, 2025. For fiscal 2024 it was $4.05K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.05K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $10.54K | – |
| Q2 FY2025 | Jun 30, 2025 | $187.97K | – |
| Q1 FY2025 | Mar 31, 2025 | $91.91K | – |
| Q4 FY2024 | Dec 31, 2024 | $4.05K | – |
See a number that looks wrong?